CN105641255A - 一种消炎开窍明目滴眼液及其制备方法 - Google Patents
一种消炎开窍明目滴眼液及其制备方法 Download PDFInfo
- Publication number
- CN105641255A CN105641255A CN201610175529.6A CN201610175529A CN105641255A CN 105641255 A CN105641255 A CN 105641255A CN 201610175529 A CN201610175529 A CN 201610175529A CN 105641255 A CN105641255 A CN 105641255A
- Authority
- CN
- China
- Prior art keywords
- parts
- liquid
- eye drops
- prepared
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003889 eye drop Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 206010061218 Inflammation Diseases 0.000 title abstract description 11
- 230000004438 eyesight Effects 0.000 title abstract description 10
- 230000004054 inflammatory process Effects 0.000 title abstract description 8
- 230000001939 inductive effect Effects 0.000 title abstract description 4
- 229940012356 eye drops Drugs 0.000 title abstract 7
- 230000003467 diminishing effect Effects 0.000 title abstract 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 30
- 210000000582 semen Anatomy 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229960003080 taurine Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 63
- 239000007788 liquid Substances 0.000 claims description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 244000241838 Lycium barbarum Species 0.000 claims description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 16
- 235000015468 Lycium chinense Nutrition 0.000 claims description 15
- 235000013399 edible fruits Nutrition 0.000 claims description 15
- 244000167230 Lonicera japonica Species 0.000 claims description 14
- 235000017617 Lonicera japonica Nutrition 0.000 claims description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 13
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 7
- 239000008227 sterile water for injection Substances 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 3
- 235000011613 Pinus brutia Nutrition 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 241000233948 Typha Species 0.000 claims 5
- 239000012141 concentrate Substances 0.000 claims 1
- 210000001508 eye Anatomy 0.000 abstract description 23
- 230000000694 effects Effects 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 14
- 230000009471 action Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000005516 engineering process Methods 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 239000010231 banlangen Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 240000001398 Typha domingensis Species 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 210000000795 conjunctiva Anatomy 0.000 description 7
- 208000001860 Eye Infections Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000004087 cornea Anatomy 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000000554 iris Anatomy 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 210000000744 eyelid Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- CRDNMYFJWFXOCH-YPKPFQOOSA-N (3z)-3-(3-oxo-1h-indol-2-ylidene)-1h-indol-2-one Chemical compound N/1C2=CC=CC=C2C(=O)C\1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-YPKPFQOOSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 241000050051 Chelone glabra Species 0.000 description 2
- 206010015946 Eye irritation Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000003260 anti-sepsis Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000005252 bulbus oculi Anatomy 0.000 description 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 2
- 231100000013 eye irritation Toxicity 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 239000008518 lycium barbarum polysaccharide Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- LHXDLQBQYFFVNW-XCBNKYQSSA-N (+)-fenchone Chemical compound C1C[C@]2(C)C(=O)C(C)(C)[C@H]1C2 LHXDLQBQYFFVNW-XCBNKYQSSA-N 0.000 description 1
- 229930006731 (1S,4R)-fenchone Natural products 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241001503991 Consolida Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- CRDNMYFJWFXOCH-BUHFOSPRSA-N Couroupitine B Natural products N\1C2=CC=CC=C2C(=O)C/1=C1/C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-BUHFOSPRSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 206010015943 Eye inflammation Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 206010024769 Local reaction Diseases 0.000 description 1
- 208000035719 Maculopathy Diseases 0.000 description 1
- 241000150100 Margo Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- SNFFBROYEDWRGB-SASFBZJPSA-N Plantagoside Natural products O([C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1c(O)c(O)cc([C@H]2Oc3c(c(O)cc(O)c3)C(=O)C2)c1 SNFFBROYEDWRGB-SASFBZJPSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000008923 Qingkailing Substances 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000134857 Typha capensis Species 0.000 description 1
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000034700 Vitreous opacities Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 210000002159 anterior chamber Anatomy 0.000 description 1
- RGHILYZRVFRRNK-UHFFFAOYSA-N anthracene-1,2-dione Chemical class C1=CC=C2C=C(C(C(=O)C=C3)=O)C3=CC2=C1 RGHILYZRVFRRNK-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- RJWJHRPNHPHBRN-FKVJWERZSA-N aucubin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=C[C@@H](O)[C@@H]2C=CO1 RJWJHRPNHPHBRN-FKVJWERZSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000007336 cyanidin Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004968 inflammatory condition Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- CRDNMYFJWFXOCH-UHFFFAOYSA-N isoindigotin Natural products N1C2=CC=CC=C2C(=O)C1=C1C2=CC=CC=C2NC1=O CRDNMYFJWFXOCH-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 206010023683 lagophthalmos Diseases 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 150000002887 oleanolic acids Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- SNFFBROYEDWRGB-NHXQFOETSA-N plantagoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC([C@H]2OC3=CC(O)=CC(O)=C3C(=O)C2)=CC(O)=C1O SNFFBROYEDWRGB-NHXQFOETSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- HDDDNIUXSFCGMB-UHFFFAOYSA-N quercetin 3-galactoside Natural products OCC1OC(OC2=C(Oc3ccc(O)c(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C(O)C1O HDDDNIUXSFCGMB-UHFFFAOYSA-N 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 description 1
- 229930190376 scutellarin Natural products 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种消炎开窍明目滴眼液及其制备方法,属于中药新药技术领域,选取夏枯草、黄芩提取物、金银花、板蓝根、蒲黄、决明子、枸杞子、车前子、水牛角、牛磺酸、冰片、麝香经现代技术提取配制;全部采用常见、易取得的中草药材料,经现代技术提取配制,对于治疗眼部炎症具有较好的疗效,具有开窍明目、抗菌消炎的作用,药物直接到达作用部位,增加眼内有效药物浓度,能够提高患者的视力,适用于各种眼部感染性疾病,尚未发现不良反应,无毒副作用,经过十几年的使用效果良好。
Description
技术领域
本发明涉及一种消炎开窍明目滴眼液及其制备方法,属于中药新药技术领域。
背景技术
眼部疾患中,眼部感染症占很大比例,眼部感染性疾病主要由细菌、病毒、真菌、寄生虫等病原体侵入人体眼部所引起的组织炎症反应,常见眼皮、结膜、角膜和巩膜等部位的感染,临床治疗主要使用抗菌类滴眼液。随广谱抗菌药物的应用,病原菌菌谱及其对抗菌药物的敏感性均发生很大变化,对眼部感染的治疗提出了新的挑战。
明目中药作为祖国传统医药的重要组成部分,眼科明目中药临床运用十分广泛,计不下数十种,皆能明目。中医认为“肝开窍于目”,护眼同时也要护肝,肝不好,眼睛就会不好。如枸杞子平补肝肾、明目,平日可拿来泡茶最为实用;决明子最为常用,属于清肝明目之品,常用无毒副作用。
发明内容
本发明的目的是提供一种消炎开窍明目滴眼液及其制备方法,本滴眼液具有开窍明目、抗菌消炎的作用,药物直接到达作用部位,增加眼内有效药物浓度,能够提高患者的视力,适用于各种眼部感染性疾病。
本发明解决其技术问题所采用的技术方案是:它是由下列重量组份的原料制成:
夏枯草:1-50份,黄芩提取物(含量85%以上):1-20份,金银花:1-50份,板蓝根:1-50份,蒲黄:1-40份,决明子:1-60份,枸杞子:1-50份,车前子:1-50,份,水牛角:1-60份,牛磺酸:0.1-10份,冰片:0.1-20份,麝香:0.1-10份。
一种消炎开窍明目滴眼液的制备方法,其制备步骤是:
1、取夏枯草、金银花和板蓝根,加水煎煮二次,每次1.0小时,合并煎液,滤过,浓缩至相对密度为1.05-1.10(60℃),加入95%乙醇,使含醇量达75%,静置,滤过,回收乙醇,加注射用水200ml静置,得制备液1;
2、取黄芩提取物加注射用水100ml,用10%氢氧化钠溶液调节pH值8-9,静置,得制备液2;
3、取蒲黄、车前子,加50%乙醇200ml,冷浸24小时,滤过,浓缩至相对密度为1.05-1.10(60℃),加乙醇,使含醇量达80%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液3;
4、取决明子、枸杞子,加水煎煮二次,每次0.5小时,合并煎液,滤过,浓缩至相对密度为1.10~1.15(60℃),加入95%乙醇,使含醇量达70%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液4;
5、取水牛角,加硫酸适量,水解,滤过,滤液用10%氢氧化钠溶液调节pH值至4.5,滤过,浓缩至相对密度为1.05-1.10(60℃),放冷,加60%乙醇,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液5;
6、取牛磺酸,100ml灭菌注射用水溶解;得制备液6;
7、取冰片、麝香,加入30ml丙二醇或甘油研磨,使冰片和麝香溶解于丙二醇或甘油中,加水100ml,使其溶解,得制备液7;
将上述制备液1-6混合均与后,加入制备液7,加入5g活性炭,调节pH值至7.0,加热煮沸10min,滤过,加灭菌注射用水至1000ml。
上述各药的作用如下:
夏枯草:清热泻火,明目,散结消肿,有清火明目之功效,能治目赤肿痛、头痛等。本品含三萜皂苷、芸香苷、金丝桃苷等苷类物质及熊果酸、咖啡酸、游离齐敦果酸等有机酸;花穗中含飞燕草素、矢车菊素的花色苷、d-樟脑、d-小茴香酮等。用于肝火所致的目赤肿痛、眼底出血,眼底渗出等。
黄芩:泻实火,除湿热,能治热毒,黄芩根含黄酮类化合物:黄芩素,黄芩新素等。抗病毒作用,抗炎抗变态反应,保肝、利胆、抗氧化等药理作用,可治肺热亢盛所致的白睛红赤,睑缘赤烂、黑睛生醫、神水混浊及热毒所致的胞睑红肿生疮、眦部流脓等。
金银花:自古被誉为清热解毒的良药,能宣散风热,还善清解血毒,金银花含有绿原酸、木犀草素苷等药理活性成分,抗病原微生物作用,抗炎和解热作用。
板蓝根:具有清热解毒、预防感冒、利咽之功效,抗病原微生物作用,菘蓝根含靛蓝、靛玉红、蒽醌类、β-谷甾醇等,
蒲黄:止血,化瘀,通淋,具有行血消瘀明目,收敛止血之功。
决明子:润肠通便,降脂明目,用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。
枸杞子:枸杞子富含枸杞多糖,枸杞多糖对消除疲劳具有十分明显的作用,有抗Y射线辐射、保护机体的作用,枸杞中所含丰富的β-胡萝卜素可在人体内转化成维生素A,而维生素A可生成视黄醇,从而提高视力,防止黄斑症。用于肝肾不足所致的眼病。
车前子:利水通淋、渗湿止泻、清肝明目、清热化痰,车前种子含月桃叶珊瑚甙,车前粘多糖,消旋车前子苷等,用于水湿、痰湿滞目所致的胞睑水肿,眼珠胀硬,云雾移睛,眼底水肿渗出等。
水牛角:清热,凉血,定惊,解毒。用于热毒炽盛,迫血妄行的内眼出血及血热瘀结病。
牛磺酸:牛磺酸具有调节晶体渗透压和抗氧化等重要作用,可抑制白内障的发生发展。
冰片:具有开窍醒神、清热散毒、明目退翳的功效,用于目赤肿痛,喉痹口疮、用于疮疡肿痛,溃后不敛等,可加强其他药物的药效。
麝香:有开窍、通络之功能。《医学入门》将麝香与龙脑对比:“麝香,通关透窍,上达肌肤,内入骨髓,与龙脑相同,而香窜又过之。”。麝香能迅速透过血眼屏障,促进视网膜通透性作用。
本发明的有益效果是:全部采用常见、易取得的中草药材料,经现代技术提取配制,对于治疗眼部炎症具有较好的疗效,具有开窍明目、抗菌消炎的作用,药物直接到达作用部位,增加眼内有效药物浓度,能够提高患者的视力,适用于各种眼部感染性疾病,尚未发现不良反应,无毒副作用,经过十几年的使用效果良好。
具体实施方式
一种消炎开窍明目滴眼液及其制备方法,滴眼液它是由下列重量组份的原料制成:
夏枯草:1-50份,黄芩提取物(含量85%以上):1-20份,金银花:1-50份,板蓝根:1-50份,蒲黄:1-40份,决明子:1-60份,枸杞子:1-50份,车前子:1-50,份,水牛角:1-60份,牛磺酸:0.1-10份,冰片:0.1-20份,麝香:0.1-10份。
实施例1
由下列重量组份的原料制成:夏枯草20份、黄芩提取物3份、金银花15份、板蓝根20份、蒲黄10份、决明子20份、枸杞子20份、车前子15份、水牛角20份、牛磺酸1份、冰片1份、麝香0.5份。
实施例2
由下列重量组份的原料制成:夏枯草30份、黄芩提取物8份、金银花25份、板蓝根30份、蒲黄20份、决明子30份、枸杞子30份、车前子25份、水牛角40份、牛磺酸5份、冰片5份、麝香3份。
实施例3
由下列重量组份的原料制成:夏枯草25份、黄芩提取物5份、金银花20份、板蓝根25份、蒲黄15份、决明子25份、枸杞子25份、车前子20份、水牛角30份、牛磺酸2份、冰片3份、麝香1份。
实施例4
一种消炎开窍明目滴眼液的制备方法,其制备步骤是:
1、取夏枯草、金银花和板蓝根,加水煎煮二次,每次1.0小时,合并煎液,滤过,浓缩至相对密度为1.05-1.10(60℃),加入95%乙醇,使含醇量达75%,静置,滤过,回收乙醇,加注射用水200ml静置,得制备液1;
2、取黄芩提取物(含量85%以上),加注射用水100ml,用10%氢氧化钠溶液调节pH值8-9,静置,得制备液2;
3、取蒲黄、车前子,加50%乙醇200ml,冷浸24小时,滤过,浓缩至相对密度为1.05-1.10(60℃),加乙醇,使含醇量达80%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液3;
4、取决明子、枸杞子,加水煎煮二次,每次0.5小时,合并煎液,滤过,浓缩至相对密度为1.10~1.15(60℃),加入95%乙醇,使含醇量达70%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液4;
5、取水牛角,加硫酸适量,水解,滤过,滤液用10%氢氧化钠溶液调节pH值至4.5,滤过,浓缩至相对密度为1.05-1.10(60℃),放冷,加60%乙醇,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液5;
6、取牛磺酸,100ml灭菌注射用水溶解;得制备液6;
7、取冰片、麝香,加入30ml丙二醇或甘油研磨,使冰片和麝香溶解于丙二醇或甘油中,加水100ml,使其溶解,得制备液7;
将上述制备液1-6混合均与后,加入制备液7,加入5g活性炭,调节pH值至7.0,加热煮沸10min,滤过,加灭菌注射用水至1000ml。
作为对上述技术方案的改进,还可以向所述消炎开窍明目滴眼液中加入稀释剂、吸收剂、润湿剂、粘合剂、崩解剂、润滑剂、助悬剂、絮凝剂、反絮凝剂、甜味剂、芳香剂、调味剂、稳定剂或防腐剂中的一种或任意几种。
其动物实验是:取新西兰大白兔,雌雄各半。给药前先观察并记录每只家兔角膜、虹膜及结膜情况,已有病变或炎症者,剔除不用。试验时,将制备的滴眼液实施例1、实施例2和实施例3各0.1mL滴入兔左眼结膜囊内,右眼滴入0.1mL灭菌注射用水为对照。给药后使家兔眼睛被动闭合8~10秒,观察给药后6h、24h、48h、72h至7天。眼的局部反应情况,对角膜、虹膜及结膜分别进行评分,算出平均分值,并与家兔右眼(对照眼)进行比较。每只兔眼刺激反应总积分等于每只兔眼角膜、虹膜、结膜的刺激反应分值之和。平均分为每次观察时全部家兔眼刺激分值的平均数。然后判断清开灵眼用凝胶的眼刺激性。当角膜、虹膜及结膜的刺激强度不一致时,应分别作出评价。第7天观察后处死家兔,剪取双眼及上下眼睑,肉眼观察有无红肿、水肿。
结果表明制备的滴眼液实施例1、实施例3无角膜刺激性,滴眼液实施例2存在轻微的刺激性,但停药后刺激症状消失。
将制备的滴眼液实施例1、实施例2和实施例3各0.1mL滴入外伤性眼内炎兔子右眼结膜囊内,分别在裂隙灯及间接检眼镜下检查,仔细观察受伤眼的结膜、角膜、虹膜、前房以及玻璃体的炎症情况并进行炎症评分。
结果表明,制备的滴眼液实施例1、实施例2和实施例3均可减轻炎症评分,且滴眼液实施例2对炎症的减轻作用最明显。
Claims (5)
1.一种消炎开窍明目滴眼液及其制备方法,其特征是:滴眼液它是由下列重量组份的原料制成:
夏枯草:1-50份,黄芩提取物(含量85%以上):1-20份,金银花:1-50份,板蓝根:1-50份,蒲黄:1-40份,决明子:1-60份,枸杞子:1-50份,车前子:1-50,份,水牛角:1-60份,牛磺酸:0.1-10份,冰片:0.1-20份,麝香:0.1-10份。
2.根据权利要求1所述的一种消炎开窍明目滴眼液,其特征是:由下列重量组份的原料制成:夏枯草20份、黄芩提取物3份、金银花15份、板蓝根20份、蒲黄10份、决明子20份、枸杞子20份、车前子15份、水牛角20份、牛磺酸1份、冰片1份、麝香0.5份。
3.根据权利要求1所述的一种消炎开窍明目滴眼液,其特征是:由下列重量组份的原料制成:夏枯草30份、黄芩提取物8份、金银花25份、板蓝根30份、蒲黄20份、决明子30份、枸杞子30份、车前子25份、水牛角40份、牛磺酸5份、冰片5份、麝香3份。
4.根据权利要求1所述的一种消炎开窍明目滴眼液,其特征是:由下列重量组份的原料制成:夏枯草25份、黄芩提取物5份、金银花20份、板蓝根25份、蒲黄15份、决明子25份、枸杞子25份、车前子20份、水牛角30份、牛磺酸2份、冰片3份、麝香1份。
5.根据权利要求1所述的一种消炎开窍明目滴眼液的制备方法,其特征是:其制备步骤是:
一、取夏枯草、金银花和板蓝根,加水煎煮二次,每次1.0小时,合并煎液,滤过,浓缩至相对密度为1.05-1.10(60℃),加入95%乙醇,使含醇量达75%,静置,滤过,回收乙醇,加注射用水200ml静置,得制备液1;
二、取黄芩提取物(含量85%以上),加注射用水100ml,用10%氢氧化钠溶液调节pH值8-9,静置,得制备液2;
三、取蒲黄、车前子,加50%乙醇200ml,冷浸24小时,滤过,浓缩至相对密度为1.05-1.10(60℃),加乙醇,使含醇量达80%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液3;
四、取决明子、枸杞子,加水煎煮二次,每次0.5小时,合并煎液,滤过,浓缩至相对密度为1.10~1.15(60℃),加入95%乙醇,使含醇量达70%,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液4;
五、取水牛角,加硫酸适量,水解,滤过,滤液用10%氢氧化钠溶液调节pH值至4.5,滤过,浓缩至相对密度为1.05-1.10(60℃),放冷,加60%乙醇,静置,滤过,回收乙醇,加注射用水100ml静置,得制备液5;
六、取牛磺酸,100ml灭菌注射用水溶解;得制备液6;
七、取冰片、麝香,加入30ml丙二醇或甘油研磨,使冰片和麝香溶解于丙二醇或甘油中,加水100ml,使其溶解,得制备液7;
将上述制备液1-6混合均与后,加入制备液7,加入5g活性炭,调节pH值至7.0,加热煮沸10min,滤过,加灭菌注射用水至1000ml。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610175529.6A CN105641255A (zh) | 2016-03-26 | 2016-03-26 | 一种消炎开窍明目滴眼液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610175529.6A CN105641255A (zh) | 2016-03-26 | 2016-03-26 | 一种消炎开窍明目滴眼液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105641255A true CN105641255A (zh) | 2016-06-08 |
Family
ID=56495604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610175529.6A Pending CN105641255A (zh) | 2016-03-26 | 2016-03-26 | 一种消炎开窍明目滴眼液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105641255A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107596200A (zh) * | 2017-11-05 | 2018-01-19 | 防城港市奥氏蓝科技有限公司 | 一种明目中药滴眼液的制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682799A (zh) * | 2004-09-28 | 2005-10-19 | 徐立新 | 一种治疗细菌性、病毒性结角膜炎的眼科外用中药制剂及其制备工艺 |
CN104784367A (zh) * | 2015-05-11 | 2015-07-22 | 马莉莉 | 一种治疗虹膜睫状体急性炎症的中药滴眼液及制法 |
-
2016
- 2016-03-26 CN CN201610175529.6A patent/CN105641255A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1682799A (zh) * | 2004-09-28 | 2005-10-19 | 徐立新 | 一种治疗细菌性、病毒性结角膜炎的眼科外用中药制剂及其制备工艺 |
CN104784367A (zh) * | 2015-05-11 | 2015-07-22 | 马莉莉 | 一种治疗虹膜睫状体急性炎症的中药滴眼液及制法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107596200A (zh) * | 2017-11-05 | 2018-01-19 | 防城港市奥氏蓝科技有限公司 | 一种明目中药滴眼液的制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102362924B (zh) | 一种治疗眼科疾病的药物组合物及其制备方法 | |
CN106539083A (zh) | 一种用于预防和治疗糖尿病视网膜病变、缓解视力疲劳的组合物 | |
CN105106318B (zh) | 一种治疗干眼症的中药组合物及其制备方法 | |
CN101167884B (zh) | 一种内服用于治疗白内障的中药配方 | |
CN110123877B (zh) | 一种治疗干眼症的热敷包及其制备方法 | |
CN108653429B (zh) | 一种治疗麦粒肿疾病的中药组合物及其应用 | |
CN105125630A (zh) | 一种眼药水及制备方法 | |
CN105641255A (zh) | 一种消炎开窍明目滴眼液及其制备方法 | |
CN102198227B (zh) | 一种治疗阴虚型青光眼的中药制备方法 | |
CN104906220A (zh) | 一种治疗带状疱疹及单纯疱疹病毒性角膜炎的中药 | |
CN104857287A (zh) | 一种治疗干眼症的中药滴眼液及其制备方法 | |
CN102755549B (zh) | 一种治疗白内障的药物及其制备方法 | |
CN106620278A (zh) | 一种抑菌中药眼药水及其制备方法和应用 | |
CN104306546A (zh) | 一种用于治疗视神经萎缩的中药组合物及其汤剂、丸剂和散剂 | |
CN104983972A (zh) | 一种治疗麦粒肿的滴剂及其制备方法 | |
CN103610797B (zh) | 一种治疗湿热壅盛型角结膜炎的中药组合物 | |
CN106309779A (zh) | 具有舒缓视疲劳的眼药水及其制备方法 | |
CN106491730A (zh) | 一种治疗青光眼的中药组合物及其制备方法 | |
CN112426462B (zh) | 一种辅助治疗中心性浆液性脉络膜视网膜病变的水凝胶眼贴及其制备方法 | |
CN104771638A (zh) | 用于治疗视神经萎缩的中药组合物 | |
CN104587364A (zh) | 一种治疗葡萄膜炎的中药组合物 | |
CN103110854A (zh) | 一种治疗心经郁热型巩膜炎的中药制备方法 | |
CN116672421A (zh) | 一种预防和治疗近视眼的外用组合物及其制备方法 | |
CN113304217A (zh) | 一种用于治疗2型糖尿病性干眼和过敏性睑皮炎的中药熏眼制剂及其制备方法 | |
CN115120650A (zh) | 一种中药眼药水及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160608 |